SEARCH

SEARCH BY CITATION

References

  • 1
    Adams, J.M. & Cory, S. (1998) The Bcl-2 protein family: arbiters of cell survival. Science 281, 1322 1326.
  • 2
    Alnemri, E.S., Livingston, D.J., Nicholson, D.W., et al. ( 1996) Human ICE/CED-3 protease nomenclature. Cell 87, 171.
  • 3
    Antonsson, B., Conti, F., Ciavatta, A., et al. ( 1997) Inhibition of Bax channel-forming activity by Bcl-2. Science 277, 370 372.
  • 4
    Bakhshi, A., Jensen, J.P., Goldman, P., et al. ( 1985) Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 41, 899 906.
  • 5
    Cheng, E.H., Kirsch, D.G., Clem, R.J., et al. ( 1997) Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278, 1966 1968.
  • 6
    Chinnaiyan, A.M., Chaudhary, D., O'rourke, K., Dixit, V.M (1997 a) Role of CED-4 in the activation of CED-3. Nature 388, 728 729. (Scientific correspondence).
  • 7
    Chinnaiyan, A.M., O'rourke, K., Lane, B.R., Dixit, V.M. (1997 b) Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death. Science 275, 1122 1126.
  • 8
    Chinnaiyan, A.M., Orth, K., O'rouke, K., Duan, H., Poirier, G.G., Dixit, V.M. (1996) Molecular ordering of the cell death pathway: Bcl-2 and Bcl-xL function upstream of the Ced-3-like apoptotic proteases. J. Biol. Chem 271, 4573 4576.
  • 9
    Chittenden, T., Flemington, C., Houghton, A.B., et al. ( 1995) A conserved domain in Bak, distinct from BH1: and BH2, mediates cell death and protein binding functions. EMBO J. 14, 5589 5596.
  • 10
    Cleary, M.L. & Sklar, J. (1985) Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc. Natl. Acad. Sci. USA 82, 7439 7443.
  • 11
    Clem, R.J., Cheng, E.H., Karp, C.L., et al. ( 1998) Modulation of cell death by Bcl-XL through caspase interaction. Proc. Natl. Acad. Sci. USA 95, 554 559.
  • 12
    Conradt, B. & Horvitz, H.R. (1998) The C. elegans protein EGL-1 is required for programmed cell death and interacts with the Bcl-2- like protein CED-9. Cell 93, 519 529.
  • 13
    Datta, S.R., Dudek, H., Tao, X., et al. ( 1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91, 231 241.
  • 14
    Green, D.R. & Reed, J.C. (1998) Mitochondria and apoptosis. Science 281, 1309 1312.
  • 15
    Gross, A., Jockel, J., Wei, M.C., Korsmeyer, S.J. (1998) Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J. 17, 3878 3885.
  • 16
    Haldar, S., Jena, N., Croce, C.M. (1995) Inactivation of Bcl-2 by phosphorylation. Proc. Natl. Acad. Sci. USA 92, 4507 4511.
  • 17
    Hu, Y., Benedict, M.A., Wu, D., Inohara, N., Nunez, G. (1998) Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc. Natl. Acad. Sci. USA 95, 4386 4391.
  • 18
    Huang, D.C., Adams, J.M., Cory, S. (1998) The conserved N-terminal BH4: domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4. EMBO J. 17, 1029 1039.
  • 19
    Hunter, J.J. & Parslow, T.G. (1996) A peptide sequence from Bax that converts Bcl-2 into an activator of apoptosis. J. Biol. Chem. 271, 8521 8524.
  • 20
    Ito, T., Deng, X., Carr, B., May, W.S. (1997) Bcl-2 phosphorylation required for anti-apoptosis function. J. Biol. Chem. 272, 11671 11673.
  • 21
    Iwahashi, H., Eguchi, Y., Yasuhara, N., Hanafusa, T., Matsuzawa, Y., Tsujimoto, Y. (1997) Synergistic anti-apoptotic activity between Bcl-2 and SMN, a protein implicated in spinal muscular atrophy. Nature 390, 413 417.
  • 22
    Jurgensmeier, J.M., Xie, Z., Deveraux, Q., Ellerby, L., Bredesen, D., Reed, J.C. (1998) Bax directly induces release of cytochrome c from isolated mitochondria. Proc. Natl. Acad. Sci. USA 95, 4997 5002.
  • 23
    Kane, D.J., Ord, T., Anton, R., Bredesen, D.E. (1995) Expression of bcl-2 inhibits necrotic neural cell death. J. Neurosci. Res. 40, 1274 1277.
  • 24
    Kerr, J.F., Wyllie, A.H., Currie, A.R. (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239 257.
  • 25
    Kharbanda, S., Pandey, P., Schofield, L., et al. ( 1997) Role for Bcl-xL as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis. Proc. Natl. Acad. Sci. USA 94, 6939 6942.
  • 26
    Kluck, R.M., Bossy-Wetzel, E., Green, D.R., Newmeyer, D.D. (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275, 1132 1136.
  • 27
    Knudson, C.M. & Korsmeyer, S.J. (1997) Bcl-2 and Bax function independently to regulate cell death. Nature Genet. 16, 358 363.
  • 28
    Kroemer, G., Dallaporta, B., Resche-Rigon, M. (1998) The mitochondrial death/life regulator in apoptosis and necrosis. Annu. Rev. Physiol. 60, 619 642.
  • 29
    Lefebvre, S., Burglen, L., Reboullet, S., et al. ( 1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80, 155 165.
  • 30
    Li, P., Nijhawan, D., Budihardjo, I., et al. ( 1997) Cytochorme c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479 489.
  • 31
    Li, H., Zhu, H., Xu, C., Yuan, J. (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94, 481 490.
  • 32
    Liu, X., Kim, C.N., Yang, J., Jemmerson, R., Wang, Z. (1996) Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell 86, 147 157.
  • 33
    Luo, X., Budihardjo, I., Zou, H., Slaughter, C., Wang, X. (1998) Bid, a Bcl-2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94, 471 480.
  • 34
    Mahajan, N.P., Linder, K., Berry, G., Gordon, G.W., Heim, R., Herman, B. (1998) Bcl-2 and Bax interactions in mitochondria probed with green fluorescent protein and fluorescence resonance energy transfer. Nature Biotechnol. 16, 547 552.
  • 35
    Marzo, I., Brenner, C., Zamzami, N., et al. ( 1998) The permeability transition pore complex: a target for apoptosis regulation by caspases and Bcl-2-related proteins. J. Exp. Med. 187, 1261 1271.
  • 36
    Minn, A.J., Velez, P., Schendel, S.L., et al. ( 1997) Bcl-xL forms an ion channel in synthetic lipid membranes. Nature 385, 353 357.
  • 37
    Muchmore, S.W., Sattler, M., Liang, H., et al. ( 1996) X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death . Nature 381, 335 341.
  • 38
    Narita, A., Shimizu, S., Ito, T., et al. ( 1998) Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc. Natl. Acad. Sci. USA, in press.
  • 39
    Ng, F.W., Nguyen, M., Kwan, T., et al. ( 1997) p28 Bap31, a Bcl-2/Bcl-XL- and procaspase-8-associated protein in the endoplasmic reticulum. J. Cell Biol. 139, 327 338.
  • 40
    Oltvai, Z.N., Milliman, C.L., Korsmeyer, S.J. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609 619.
  • 41
    Pan, G., O'rourke, K., Dixit, V.M. (1998) Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex. J. Biol. Chem. 273, 5841 5845.
  • 42
    Salvesen, G.S. & Dixit, V.M. (1997) Caspases: intracellular signaling by proteolysis. Cell 91, 443 446.
  • 43
    Sattler, M., Liang, H., Nettesheim, D., et al. ( 1997) Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis . Science 275, 983 986.
  • 44
    Schendel, S.L., Xie, Z., Montal, M.O., Matsuyama, S., Montal, M., Reed, J.C. (1997) Channel formation by antiapoptotic protein Bcl- 2. Proc. Natl. Acad. Sci. USA 94, 5113 5118.
  • 45
    Schlesinger, P.H., Gross, A., Yin, X.M., et al. ( 1997) Comparison of the ion channel characteristics of proapoptotic BAX and antiapoptotic BCL-2. Proc. Natl. Acad. Sci. USA 94, 11357 11362.
  • 46
    Shimizu, S., Eguchi, Y., Kamiike, W., et al. ( 1996 a) Retardation of chemical hypoxia-induced necrotic cell death by Bcl-2 and ICE inhibitors: Possible common steps in apoptosis and necrosis. Oncogene 12, 2045 2050.
  • 47
    Shimizu, S., Eguchi, Y., Kamiike, W., et al. ( 1996 b) Bcl-2 blocks loss of mitochondrial membrane potential while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors. Oncogene 13, 21 29.
  • 48
    Shimizu, S., Eguchi, Y., Kamiike, W., et al. ( 1998) Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux. Proc. Natl. Acad. Sci. USA 95, 1455 1459.
  • 49
    Spector, M.S., Desnoyers, S., Hoeppner, D.J., Hengartner, M.O. (1997) Interaction between the C. elegans cell-death regulators CED-9 and CED-4 . Nature 385, 653 656.
  • 50
    Srinivasula, S.M., Ahmad, M., Fernandes-Alnemri, T., Alnemri, E.S. (1998) Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol. Cell 1, 949 957.
  • 51
    Srivastava, R.K., Srivastava, A.R., Korsmeyer, S.J., Nesterova, M., Cho- Chung, Y.S., Longo, D.L. (1998) Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol. Cell. Biol. 18, 3509 3517.
  • 52
    Strasser, A., Harris, A.W., Cory, S. (1991) bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67, 889 899.
  • 53
    Susin, S.A., Zamzami, N., Castedo, M., et al. ( 1996) Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184, 1331 1342.
  • 54
    Susin, S.A., Zamzami, N., Castedo, M., et al. ( 1997) The central executioner of apoptosis: Multiple connections between protease activation and mitochondria in Fas/Apo-1/CD95- and ceramide-induced apoptosis. J. Exp. Med. 186, 25 37.
  • 55
    Takayama, S., Bimston, D.N., Matsuzawa, S., et al. ( 1997) BAG-1 modulates the chaperone activity of Hsp70/Hsc70. EMBO J. 16, 4887 4896.
  • 56
    Takayama, S., Sato, T., Krajewski, S., et al. ( 1995) Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell 80, 279 284.
  • 57
    Thornberry, N.A. & Lazebnik, Y. (1998) Caspases: Enemies within. Science 281, 1312 1316.
  • 58
    Tsujimoto, Y. (1989) Stress-resistance conferred by high level of bcl-2α protein in humna B lymphoblastoid cell. Oncogene 4, 1331 1336.
  • 59
    Tsujimoto, Y., Cossman, J., Jaffe, E., Croce, C.M. (1985) Involvement of the bcl-2 gene in human follicular lymphoma. Science 228, 1440 1443.
  • 60
    Tsujimoto, Y. & Croce, C.M. (1986) Analysis of the structure transcripts and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA 83, 5214 5218.
  • 61
    Tsujimoto, Y., Finger, L.R., Yunis, J., Nowell, P.C., Croce, C.M. (1984) Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 226, 1097 1109.
  • 62
    Vander Heiden, M.G., Chandel, N.S., Williamson, E.K., Schumacker, P.T., Thompson, C.B. (1997) Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 91, 627 637.
  • 63
    Vaux, D.L., Cory, S., Adams, J.M. (1988) bcl-2 gene promotes haematopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335, 440 442.
  • 64
    Wang, H.-G., Rapp, U.R., Reed, J.C. (1996 a) Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 87, 629 638.
  • 65
    Wang, K., Yin, X.M., Chao, D.T., Milliman, C.L., Korsmeyer, S.J. (1996 b) BID: a novel BH3 domain-only death agonist. Genes Dev. 10, 2859 2869.
  • 66
    Wolter, K.G., Hsu, Y.T., Smith, C.L., Nechushtan, A., Xi, X.G., Youle, R.J. (1997) Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol. 139, 1281 1292.
  • 67
    Wu, D., Wallen, H.D., Nunez, G. (1997) Interaction and regulation of subcellular localization of CED-4 by CED-9. Science 275, 1126 1129.
  • 68
    Yang, J., Liu, X., Bhalla, K., et al. ( 1997) Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 275, 1129 1132.
  • 69
    Yang, E., Zha, J., Jockel, J., Boise, L.H., Thompson, C.B., Korsmeyer, S.J. (1995) Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces Bax and promotes cell death. Cell 80, 285 291.
  • 70
    Yasuhara, N., Sahara, S., Kamada, S., Eguchi, Y., Tsujimoto, Y. (1997) Evidence against a functional site for Bcl-2 downstream of caspase cascade in preventing apoptosis. Oncogene 15, 1921 1928.
  • 71
    Zamzami, N., Brenner, C., Marzo, I., Susin, S.A., Kroemer, G. (1998) Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins. Oncogene 16, 2265 2282.
  • 72
    Zha, J., Harada, H., Yang, E., Jockel, J., Korsmeyer, S.J. (1996) Serine phosphorylation of death agonist Bad in response to survival factor results in binding to 140-3-3 not Bcl-xL. Cell 15, 619 628.
  • 73
    Zhu, W., Cowie, A., Wasfy, G.W., Penn, L.Z., Leber, B., Andrews, D.W. (1996) Bcl-2 mutants with restricted subcellular location reveal spatially distinct pathways for apoptosis in different cell types. EMBO J. 15, 4130 4141.
  • 74
    Zoratti, M. & Szabo, I. (1995) The mitochondrial permeability transition. Biochim. Biophys. Acta 1241, 139 176.
  • 75
    Zou, H., Henzel, W.J., Liu, X., Lutschg, A., Wang, X. (1997) Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90, 405 413.